Synthesis and blood glucose lowering activity of some novel benzenesulfonylthiourea derivatives substituted with 4-aryl-1-oxophthalazin-2(1H)yl-ones

References

• Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477–90
   PubMed Web of Science ®Google Scholar
• Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. Engl J Med 1993;329:1988–92
   PubMed Web of Science ®Google Scholar
• Sulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171–6
   PubMed Web of Science ®Google Scholar
• Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3–19
   PubMed Web of Science ®Google Scholar
• LeRoith D. β-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med 2002;113:3–11
   Web of Science ®Google Scholar
• Robertson RP, Harmon J, Tran PO. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004;53:5119–24
   Web of Science ®Google Scholar
• Kecskemeti V, Bagi Z, Posa I, et al. New trends in the development of oral antidiabetic drugs. Curr Med Chem 2002;9:53–71
   PubMed Web of Science ®Google Scholar
• Muller G, Hartz D, Punter J, et al. Differential interaction of glimperide and glibenclamide with β-cell sulfonylurea receptor. Biochim Biochim Acta 1994;1191:267--77
   PubMed Web of Science ®Google Scholar
• Schade DS, Jovanovic L, Schneider J. A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful. J Clin Pharmacol 1998;38:636–41
   PubMed Web of Science ®Google Scholar
• Zimmerman BR. Sulfonylureas. Endocrinol Metab Clin North Am 1997;26:511–21
   PubMed Web of Science ®Google Scholar
• Simonson DC, Ferrannini E, Bevilacqua S, et al. Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 1984;33:838–45
   PubMed Web of Science ®Google Scholar
• Kilo C, Meenan A, Bloomgaren Z. Glyburide versus glipizide in the treatment of patients with noninsulin-dependent diabetes mellitus. Clin Ther 1992;14:801–12
   Google Scholar
• Klepzig H, Kober G, Matter C, et al. Sulfonylureas and ischaemic preconditioning. A double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999;20:403–5
   Google Scholar
• Anderson JW, Kendall CWC, Jenkins DJA. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Nut 2003;22:331–9
   PubMed Web of Science ®Google Scholar
• Kimmel B, Inzucchi SE. Oral agents for type 2 diabetes: an update. Clin Diab 2005;23:64–76
   Google Scholar
• Kawanishi K, Ueda H, Moriyasu M. Aldose reductase inhibitors from the nature. Curr Med Chem 2003;10:1353–74
   PubMed Web of Science ®Google Scholar
• Costantino L, Rastelli G, Vescovini K, et al. Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors. J Med Chem 1996;36:4396–405
   Google Scholar
• Costantino L, Rastelli G, Cignarella G, Barlocco D. Synthesis and aldose reductase inhibitory activity of a new series of benzo[H]cinnolinone derivatives. Farmaco 2000;55:544–52
   PubMedGoogle Scholar
• Courdert P, Duroux E, Bastide P, Couquelet J. Synthesis and evaluation of the aldose reductase inhibitory activity of new diaryl pyridazine-3-ones. J Pharm Belg 1991;46:375–80
   PubMedGoogle Scholar
• Napoletano M, Norcini G, Pellacini F, et al. Phthalazine PDE4 inhibitors. Part 2: the synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives. Bioorg Med Chem Lett 2001;11:33–7
   Google Scholar
• Pushparaj PN, Low HK, Manikandan J, et al. Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. J Ethnopharmacol 2007;111:430–4
   PubMed Web of Science ®Google Scholar
• Murali B, Upadhyaya UM, Goyal RK. Effect of chronic treatment with Enicostemma littorale in non-insulin dependent diabetic (NIDDM) rats. J Ethnopharmacol 2002;81:199–204
   PubMed Web of Science ®Google Scholar
• Ghaffar NF, Mohamed MA, Ghanem HM, Zaki HM. Synthesis and biochemical evaluation of some substituted phthalazines. J Am Sci 2011;7:771–81
   Google Scholar
• Olmo ED, Barboza B, Ybarra MI, et al. Vasorelaxant activity of phthalazinones and related compounds. Bioorg Med Chem Lett 2006;16:2786–90
   PubMed Web of Science ®Google Scholar
• Yaseen S. Synthesis of blood glucose lowering heterocyclic compounds [PhD thesis]. New Delhi: Jamia Hamdard (To be submitted)
   Google Scholar
• Laudadio C, Sima AA. Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial. J Diabetes Complications 1998;12:121–7
   PubMed Web of Science ®Google Scholar